San Diego, CA – October 24, 2017 – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that CEO Dr. Stuart Titus will be speaking at the Community Alliance Program’s First Annual Cannabis 4 the Cause event on Saturday, December 9 2017 at the Montezuma Hall on the San Diego State University campus. He will join other industry experts including retired professional NFL player, Kyle Turley in a discussion on Chronic Traumatic Encephalopathy (CTE), a disease plaguing NFL players across the nation, and cannabinoid research being conducted by the Company and others for treatment of the debilitating disease.

Dr. Titus will focus on discussing research, milestones, and protocol to help prevent additional brain injury in current CTE patients and those at risk as well as cover current research and development on cannabinoids therapy that is intended to act as a preventative and therapeutic modality for treating CTE.

“We are honored to participate in the first ever public cannabis event being held at the
university,” said Dr. Titus. “With more and more cases of CTE being diabgosised every day, this
subject may be one of the most important areas of interest for our companies in our mission to
help patients around the world.”

Company portfolio company Kannalife Sciences holds the exclusive license from the federal government to commercialize a medical marijuana patent currently held by the National Institutes of Health (NIH). They are currently doing research on various cannabinoids as a neuroprotectant and treatment for CTE patients under a license from the NIH 507 patent as discussed in this Sport Illustrated article. CTE is a degenerative brain condition found in those who have suffered repetitive brain trauma, such as NFL players who are constantly getting hit on the head throughout the course of a regular-season NFL game on any given Sunday.

About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit.We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

This press release may contain certain forward-looking statements and information, as defined
within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections.
This material contains statements about expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties. Such forward-looking
statements by definition involve risks, uncertainties.

The statements in this press release have not been evaluated by the Food and Drug
Administration (FDA) and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P: 888-829- 0070
[email protected]